CTSB and metabolic dysfunction-associated steatohepatitis: In contrast, the consistent increase in SIRT1 activity, both after LPS challenge in control and CCl4-exposed mice, and in the NASH murine model, obtained by CTSB inhibition, revealed to be a highly effective strategy to recover SIRT1 levels in the damaged liver.